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The global dissemination of the multiply-antibiotic-resistant Salmonella enterica serovar Typhimurium DT104 
clone with the resistance genes located in a class 1 integron, here designated Inl04, within genomic island SGI1 
is a significant public health issue. Here, we have shown that SGI1 and variants of it carrying diiferent combi­
nations of resistance genes are found in several Salmonella enterica serovars. These are serovars Cerro, Derby, 
Dusseldorf, Infantis, Kiambu, and Paratyphi B dT+ isolated from human infections and serovar Emek from sewage 
effluent. Two new variants, SGI1-I and SGI1-J, both of which include the dfrA I-url'C cassette array, were identified.
Most multiply-antibiotic-resistant (MR) Salmonella enterica 
serovar Typhimurium DT104 isolates exhibit resistance to am- 
picillin, chloramphenicol, florfenicol, streptomycin, spectino- 
mycin, sulfonamides, and tetracycline but, because screening 
for spectinomycin and florfenicol resistance is not routine, are 
often incorrectly described as “pentaresistant.” Multidrug re­
sistance in the majority of DT104 strains is due to the p res­
ence of five genes aadA2, still, floR, tetA(G), and blaPl (vari­
ant form fc/rtpsE.! or blaCARB_2) that confer resistance to 
streptomycin and spectinomycin, sulfonamides, chloramphen­
icol and florfenicol, tetracyclines, and (3-lactam antibiotics, re­
spectively (4, 5). These isolates represent a single clone that 
has emerged as a dominant serovar Typhimurium clone glo­
bally and has been isolated from humans, most m eat-produc­
ing animals, exotic birds, and various foods, including meat, 
dairy products, and salad ingredients (43, 45).
Molecular typing studies have shown that this MR DT104 
clone appeared simultaneously in the United Kingdom, E u­
rope, and the United States during the mid-f980s (9). MR 
DTJ04 with the same resistance profile (ampicillin, chlor­
amphenicol, streptomycin, sulfonamides, and tetracycline) 
had been isolated from humans in Asia prior to 1982 (22), 
but it is not currently known if these are identical to the 
globally dissem inated clone. M R DTJ04 is now the second 
most prevalent Salmonella serotype isolated from humans in
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South Wales 2570, Australia. Phone: 61246-406426. Fax: 61246-406384. 
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§ Present address: Centre for Infectious Diseases and Microbiology, 
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the U nited Kingdom, and the incidence of this clone has in ­
creased significantly in the U nited States, South Africa, the 
U nited Arab Em irates, Trinidad, the Philippines, the Irish 
Republic, Canada, Israel, Japan, and most European countries 
(36, 43, 45). However, M R DT104 has not taken hold in Aus­
tralia, where it has been detected only infrequently in imported 
foods and travelers returning from overseas (D. Lightfoot, 
unpublished observations).
The resistance genes in the major M R DT104 clone all he 
within the boundaries of a large (13 kb) class 1 integron with a 
complex structure, here named Inl04 (Fig. 1). The sequence of 
this region (4, 5) has revealed that the integron has a backbone 
similar to that of In4 (28, 29), but it includes duplications of 
parts of the integron conserved segments (CS), specifically, 
part of the in tll gene from the 5'-CS and part of the 3'-CS 
(qacEA.1 and partial still genes) that normally flank integrated 
gene cassettes (16, 17). As a consequence, Inl04 includes two 
attll sites, into which gene cassettes can be incorporated (8,16, 
17, 35), with the aadA2 gene cassette in one and the blaPl 
cassette in the other (37, 39). This arrangement produces a 
characteristic pair of PCR products of 1.0 kb and 1.2 kb using 
standard primers that amplify the cassette-containing regions, 
and these regions have often been called InC and InD (37, 39), 
assuming there are two integrons rather than one. The floR  and 
tetRA(G) genes he between the two integron-derived regions (5) 
together with an open reading frame, orf2, that is potentially 
part of an unusual type of insertion sequence recently named 
CR3 (32).
In l04 lies within a genomic island known as SGI1 (4) (Gen- 
Bank accession no. AF261825). It appears to have moved to 
this location by transposition because there is a 5-bp direct 
duplication flanking the 25-bp inverted repeats (IRs) of the
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FIG. 1. Structure of SGI1 regions. (A) The SGI1 region of serovar Typhimurium DT104 (from GenBank accession no. AF261825) is drawn 
to scale except for Inl04, which is to scale in B. The SGI1 backbone and the retron element (shown above) are represented by open boxes, and 
the chromosomal and Inl04 regions as lines of different thicknesses. Vertical bars indicate the IR bounding Inl04. Fragments amplified by PCR 
are shown as thin lines below, with the primer pairs used (Table 1) indicated underneath. (B) Inl04 region. Dashed lines represent the surrounding 
SGI1 backbone and narrow vertical bars represent the IRs (IRi and IRt). The 5'-CS, 3'-CS, and tni regions of class 1 integrons are indicated by 
lines of different thicknesses, with attll as a tall open box and gene cassettes as open boxes with a black bar at one end, indicating the 59-be. IS6100 
and the central, non-integron-derived region are open boxes. Arrows indicate the position and orientation of genes and ORFs. Primer pairs used 
to detect the boundaries of Inl04 or to determine the size of the cassette array and the location of cassettes are indicated above or below.
integron and it is located in a presumptive res site adjacent to 
a resolvase gene (tnpR) in the SGI1 backbone, which is where 
class 1 integrons are most commonly found (18, 29). SGI1 has 
been completely sequenced and is a 43-kb genomic island 
located in the chromosome between the thdF and yidY  genes 
(4). Based on the fact that an int gene encoding a site-specific 
recombinase belonging to the tyrosine recombinase family was 
found within SGI1, at the left-hand end adjacent to the thdF 
gene, SGI1 is likely to have been integrated into the chromo­
some by site-specific recombination (4).
A  second integrated element that also includes an int gene 
and that has been called a retron-phage was found between 
SGI1 and the yidY  gene in DT104 strains (4) but is not usually 
present in other S. enterica serovars (3, 10, 12, 13, 24). SGI1 
was subsequently found in serovar Typhimurium strains typed 
as D T I, DT12, DT120, and U302 (3, 6, 19), but it has been 
shown that the DT12 and DT120 strains probably arose by 
changes in the phage susceptibility of the SGI1-containing 
DT104 strain (19). However, SGI1 has also been found in 
other serovars with diverse sources; Agona isolated from poul­
try in Belgium (3,10), Paratyphi B dT+ (formerly biovar Java) 
from tropical fish in Singapore (24), Albany from food fish in 
Thailand (12), Meleagridis from an unspecified animal in the 
United States (14), and Newport, isolated from a human (13), 
confirming that it is not confined to the serovar Typhimurium
or to DT104 strains and suggesting that it may be able to 
spread by horizontal transfer.
Variations in the structure of the integron, all of which could 
have arisen by homologous recombination, have also been 
identified (3, 6, 10, 12, 13). One type of variation involves loss 
of some of the resistance genes, which can occur via homolo­
gous recombination between one or other pair of duplicated 
regions, namely the 5'-CS or 3'-CS, causing loss of either aadA2, 
floR, and tet(G) or floR, tet(G), and blaPl (3, 6). O ther varia­
tions involve the exchange of one or both of the cassette arrays 
to introduce different gene cassettes (10, 12, 13), which can also 
occur via homologous recombination (30, 31). A  further source 
of variation (3) is the acquisition of the dfrAlO trimethoprim 
resistance gene (27) together with the sequences that flank it in 
a different type of complex class 1 integron that has a dupli­
cated 3'-CS and a potential insertion sequence, CR1, that is 
related to CR3 (3, 32). Acquisition of this segment introduces 
an additional copy of the sull gene and has been shown ex­
perimentally to occur via homologous recombination (30).
Here we have screened a set of resistant and M R S. enterica 
isolates belonging to 20 different serovars and derived from 
various sources for the presence of SGI1. All strains were 
isolated in Australia and originated from human infections, 
acquired either locally and overseas, or from sick animals or 
environmental sources in Australia. The structure of the class
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TABLE 1. Primers
Primer Sequence (5 '-3') Location Nucleotide positions Accession no. Reference17
U7-L12 ACA CCT TGA GCA GGG CAA AG thdF 1-20 AF261825.2 4
LJ-R1 AGT TCT AAA GGT TCG TAG TCG int 500-480 AF261825.2 4
SGI19-F3 TTC TTC AAT GCG CGC TTT GG S023 19009-19028 AF261825.2 This study
S026-FW TCG GGT AAT CTC AGC AGA GC S026 25021-25040 AF261825.2 6
int-RV GGG CAT GGT GGC TGA AGG ACC intll 27266-27246 AF261825.2 6
LI GGC ATC CAA GCA GCA AGC 5'-CS 27892-27909, 37164-37181 AF261825.2 21
R1 AAG CAG ACT TGA CCT GAT 3'-CS 28900-28883, 38360-38343 AF261825.2 21
aadA2-L TGT TGG TTA CTG TGG CCG aadA2 28146-28163 AF261825.2 26
aadA2-R2 TGC TTA GCT TCA AGT AAG ACG aadA2 28683-28663 AF261825.2 3
QS-1 ATG AAA GGC TGG CTT TTT CTT G qacEisl 28953-28974, 38413-38424 AF261825.2 4
sull-F GTG ACG GTG TTC GGC ATT CT sull 29297-29316, 35757-35776 AF261825.2 20
QS-2 TGA GTG CAT AAC CAC CAG CC sull 29674-29655, 31934-31915 AF261825.2 4
MDR-7 AAC CGT GCA TCT ATC GAG C __b 30094-30112 AF261825.2 3
StCM-L CAC GTT GAG CCT CTA TAT GG floR 30640-30659 AF261825.2 3
StCM-R ATG CAG AAG TAG AAC GCG AC floR 31527-31508 AF261825.2 3
F6 TTG GAA ACA GAC GGC ATG G tetR(G) 31995-31977 AF261825.2 3
tetG-L CAG CTT TCG GAT TCT TAC GG tetA(G) 32819-32838 AF261825.2 26
tetG-R GAT TGG TGA GGC TCG TTA GC tetA(G) 33662-33643 AF261825.2 26
orfl-F CGC CGA ATA TCT CAA CTT CCG orfl 33927-33947 AF261825.2 This study
orfl-R CCG CGA TGC CGA AAT CCC orfl 34581-34564 AF261825.2 This study
orf2-F2 ATG CAG TGA GAA GCC GC orf2 35291-35307 AF261825.2 This study
orf2-R2 TAC TCG AGC ACG GCT TC orf2 36024-36008 AF261825.2 This study
groEL-F ATG CCG CCC ATA CCG CCA GC groEL 36490-36509 AF261825.2 This study
pse-L AAT GGC AAT CAG CGC TTC CC blaPl 37495-37514 AF261825.2 26
pse-R2 ACA ATC GCA TCA TTT CGC TC blaPl 38147-38128 AF261825.2 3
sull-R TTT ACA GGA AGG CCA ACG GT sull 39424-39405 AF261825.2 20
orf5-F AGG TTG TGC GGC TGA TGC orf5 39776-39793 AF261825.2 This study
orf5-R2 CGA GTT CTA GGC GTT CTG C orf5 40213^0195 AF261825.2 This study
orf6-R ACT ATC TTC GGC CTT CAC ACG orf6 40508^0488 AF261825.2 This study
DB-T1 TGC CAC GCT CAA TAC CGA C IS 6100 41120^1138 AF261825.2 3
IS6100-Rv2 AAT GGT GGT TGA GCA TGC C IS 6100 41475^1457 AF261825.2 This study
MDR-BC GAA TCC GAC AGC CAA CGT TCC S044 41905^1884 AF261825.2 3
104-RJ TGA CGA GCT GAA GCG AAT TG S044 42373^2392 AF261825.2 3
C9-L2 AGC AAG TGT GCG TAA TTT GG Retron element 42868^2887 AF261825.2 3
104-D ACC AGG GCA AAA CTA CAC AG yidY 47130^7111 AF261825.2 3
dfrAl-F CGA AGA ATG GAG TTA TCG G dfrAl 621-639 X17477.1 This study
dfrAl-R TTA GAG GCG AAG TCT TGG dfrAl 1029-1012 X17477.1 This study
orfC-F CAT TAC GAA GCG AAT GCA CC orfC 1172-1191 X17477.1 This study
orfC-R TCT CGA ATC AAG CAG GAA CC orfC 1534-1515 X17477.1 This study
orf513-F ATG TCG CTG GCA AGG AAC G orf513 3521-3539 L06418.4 This study
RH379 ACC AGA GCA TTC GGT AAT CAA G dfrAl 0 5530-5551 L06418.4 This study
RH380 GCT TCA GAT AAT AAA CCA ACA CCA CC dfrAl 0 5828-5803 L06418.4 This study
a References a re  for the  primer. 
b M DR-7 targets the  sequence preceding floR.
c T he  sequence from AF261825.2 is GAATCCGACAGCCAACGCTTCC.
1 integron in isolates containing SGI1 was analyzed and com­
plete maps were derived using a variety of methods.
MATERIALS AND METHODS 
Strain collection. A  total o f 76 S. enterica strains isolated in Australia in 1999 
o r 2001 and submitted to  the  Microbiological Diagnostic U nit for typing were 
examined. O f these, 39 isolates were from humans with infections, with 16 
isolates recorded as acquired overseas (recently returned travelers), and the 
rem ainder presumed to  be acquired locally. The rest o f the  collection consisted 
o f 36 isolates from Australian animals, pigs (10 isolates), cattle (9 isolates), 
chickens (9 isolates), ducks (5 isolates), horses (2 isolates), and cats (1 isolate), 
all presumed to  be associated with disease, and one isolate from sewage effluent. 
A  total o f 20 different serovars, determ ined using standard procedures (33), were 
included in the collection. T he  collection contained 14 isolates of serovars Ty­
phimurium (six from humans: four bovine; two porcine: two equine), and Hadar 
(nine human: five duck), seven serovar Sofia (two human: five chicken), six each 
o f serovars Infantis (two human; three  chicken; one cat) and Bovismorbificans 
(one human; five bovine), four Derby (two human; two porcine) and Agona (two 
human; two porcine), three  Kiambu (two human; one chicken), two each of 
Blockley (hum an), Havana (one human; one porcine), Ohio (porcine), Paratyphi 
B d T + (biovar Java) (hum an), Singapore (human), Stanley (human), single 
isolates o f Cerro, Dusseldorf, Enteritidis, M ontevideo (all human), and Seften- 
berg (porcine), and a  single serovar Em ek isolate from sewage effluent.
All strains had been shown to  be resistant to a t least one o f the following 
antibiotics a t the  concentrations shown: ampicillin (Ap, 32 fxg/nil), chloram phen­
icol (Cm, 10 pg/ml), gentamicin (Gm, 2.5 pg/ml), kanamycin (Km 10 pg/ml), 
streptomycin (Sm, 25 fxg/nil), spectinomycin (Sp, 50 jxg/ml), sulfathiazole (Su, 
550 fxg/nil), tetracycline (Tc, 20 fxg/nil), o r trim ethoprim  (Tp, 50 pg/ml) using 
procedures described previously (1, 2). T he collection included a  broad range of 
resistance profiles with six isolates resistant to  only one o f these antibiotics, 18 
isolates resistant to two antibiotics, nine resistant to  three antibiotics, seven 
resistant to  four, and 36 resistant to  five or m ore (up to nine) antibiotics. 
Resistance to  nalidixic acid (Na, 50 pg/ml) and ciprofloxacin (Cp, 2 fxg/nil) was 
also recorded in some isolates, mainly from humans. A  single SGI1-containing 
DT'104 strain, isolated from a  hum an and traced back to an imported food (15), 
was included for comparison.
PCR. T he prim ers used a re  listed in Table 1. For initial PCR screening, 5 pi 
of tem plate prepared by resuspending a  single colony in 1 ml of sterile Milli-Q 
water, heating to  100°C for 5 min, and pelleting debris by centrifugation (13,000 
rpm, 10 min) was used. DNA o f higher purity was isolated using a  standard 
protocol (38), and 10 to 50 ng was used in all subsequent analyses. For detailed 
PCR mapping, DNA fragments were amplified in a  reaction mixture (final 
volume of 50 pi) containing 10 mM T ris-H Q  (pH 8.3), 10 mM KC1,2 mM MgCty 
and 0.2 mM of each deoxynucleoside triphosphate with 20 pmol o f each prim er 
and 1 U o f Taq DNA polymerase. Therm al cycling conditions consisted o f an 
initial denaturation cycle (95°C, 5 min) followed by 35 cycles of denaturation
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T A B L E  2. A n a ly sis  o f  th e  b o u n d a r ie s  o f  S G I1  a n d  In  104 w ith in  S G I1  in m u ltip le -a n tib io tic -re s is ta n t Sa lm o n e lla  spp .
Strain Serovar Source Country" D ate of isolation (day/mo/yr)
Junctions*
SGI LJ SGI RJ In i 04 LJ In i 04 RJ
S R C  4 D e rb y H u m a n M alay sia 20/05/99 + + + +
S R C  5 C e r ro H u m a n T h a ila n d 10/09/99 + + + +
S R C  i c r K ia m b u H u m a n A u stra lia 01/08/99 + + + +
S R C  I F K ia m b u H u m a n A u stra lia 01/04/99 + + + +
S R C  19e E m e k E fflu e n t A u s tra lia 15/09/99 + + — —
S R C  38 D u ss e ld o rf H u m a n M alay sia 30/08/01 + + + +
S R C  46 In fa n tis H u m a n A u stra lia 10/02/01 + + + +
S R C  49* P a ra ty p h i B d T + H u m a n A u stra lia 04/09/01 + + + +
S R C  50* P a ra ty p h i B d T + H u m a n A u stra lia 02/05/01 + + + +
D T 1 0 4 -2 T y p h im u riu m H u m a n A u stra lia^ ??/05/01 + __d + +
a Countries listed represent regions recently visited by affected patients.
b Primer pairs used (3, 4) with product sizes in brackets are SGI1-LJ, U7-L12, and LJ-R1 (0.5 kb); SGI1 R J, 104-RJ, and 104-D (0.5 kb); In'104 LJ, S026FW, and 
int-RV (2.245 kb); In l04  RJ, DB-T1, and MDR-B (0.786 kb). 
c Same species isolates 10 and 11 o r 49 and 50 are not known to  be epidemiologically linked. 
d D T'l04 strains with SGI1 possess a  retron elem ent that disrupts the boundary spanned by prim ers 104-RJ/104-D. 
e Primers SGI19(F3) and int-RV w ere used to  link the SGI1 backbone to In i04 in SRC19.
-^Isolate linked to  the  consumption o f halva (origin, Turkey) contam inated with DT'l04 (15).
(95°C, 30 s), annealing a t tem peratures ranging from 57 to  65°C (30 to  60 s), and 
extension (72°C, 60 to 120 s), and a  final cycle of amplification (72°C, 5 min). 
Annealing tem peratures for all prim er pairs shown in Fig. 1 w ere 60°C except for 
groEL-F/pse-R2 (65°C), groEL-F/orfC (65°C), and L l /R l (57°C). Amplified 
DNA fragments were resolved by electrophoresis using a  1 to 2%  (wt/vol) 
agarose gel, stained with ethidium brom ide (5 fxg/nil), visualized with UV, and 
imaged using a  GelDoc 1000 image analysis station (Bio-Rad, Hercules, CA).
Hybridization probes for tet(G) (amplified with the tetG -L and tetG -R  prim­
ers) and orf2 (amplified using orf2-F2 and orf2-R2 prim ers) were labeled with 
digoxigenin using the  digoxigenin Easy Hyb kit (Roche Diagnostics Corporation, 
Indianapolis, Indiana) and the m anufacturer’s instructions. PCR cycling condi­
tions consisted o f a  denaturation cycle (94°C, 5 min) followed by 30 cycles of 
denaturation (94°C, 30 s), annealing a t 60°C for tet(G) and 64°C for orf2 (30 s), 
and extension (72°C, 90 s), and a  final extension cycle (72°C, 10 min).
Southern hybridization. DNA was digested with Bsal, resolved by electro­
phoresis through 0.7% agarose, and transferred to N + nylon m em brane (Am- 
ersham, Buckinghamshire, United Kingdom) by capillary action as described 
previously (38). T he DNA was cross-linked to the  m em brane by baking a t 80°C 
for 2 h and exposed to denatured digoxigenin-labeled tet(G) and orf2 probes 
overnight a t 42°C. M embranes were then washed twice with 2 x  SSC (1 X SSC is
0.15 M NaCl plus 0.015 M sodium citrate)/0.1%  sodium dodecyl sulfate (SDS) 
for 15 min a t room tem perature and twice, m ore stringently, with 2 x  SS(70.'1% 
SDS for 15 min a t 68°C. Bands were visualized fluorescently using standard 
protocols supplied the m anufacturer (Roche Diagnostics Corporation). Digoxi­
genin-labeled molecular mass markers (molecular m arker set II, R oche Diag­
nostics Corporation) w ere included on all membranes.
DNA sequencing. PCR products w ere prepared for sequencing using the  QIA- 
quick PCR purification kit (QIA G EN , Hilden, Germany) following protocols 
supplied by the manufacturer. Sequencing was perform ed using the  Big Dye 
Term inator reaction mix version 3.2 (Applied Biosystems, Foster City, CA). 
Cycle sequencing reactions (20 jxl final volume) contained a  PCR amplicon (30 
to 90 ng), 3.2 pmol o f prim er, and 8 pi o f reaction mix and consisted o f 28 cycles 
o f denaturation (90°C, 30 s), annealing (50°C, 15 s) and extension (60°C, 240 s).
Nucleotide sequence accession number. T he sequence o f the  Emek (SGI1-J) 
drfAl-oxiC  cassette array has been submitted to  the GenBank database under 
accession no. AY963803.
RESULTS
Identification of SGI 1-containing strains. All strains were 
screened by PCR for the presence of SGI1 with or without the 
retron element using published primer pairs (3) (Table 1) that 
span the boundaries of SGI1 with the chromosome or with the 
retron element (Fig. 1A). The M R DT104 control and nine 
isolates representing seven serovars, Cerro, Derby, Dusseldorf, 
Emek, Infantis, Kiambu (two isolates), and Paratyphi B dT+ 
(two isolates), contained both ends of SGI1 (Table 2). The
retron element was found only in the DT104 control (data not 
shown). These strains (Table 2) included 8 of the 39 human 
isolates in the collection but none originating from animals. 
The ninth strain was from sewage effluent.
To determine if the integron characteristic of SGI1 and its 
variants was present, published primer pairs (3, 6) spanning the 
boundaries of In l04 with the SGI1 backbone (Fig. IB) were 
used. PCR amplification yielded products of the sizes expected 
for the integron located in SGI1 in all except the serovar Emek 
strain, where neither boundary was detected (Table 2). How­
ever, using the outward-facing prim er internal to the integron 
together with primers in other SGI1 backbone genes, the left 
or IRi end of a class 1 integron was found adjacent to part of 
the S023 gene. The sequence of this fragment revealed that 
6,889 bp of SGI1 backbone sequence normally found adjacent 
to the IRi end of the integron was missing. Primers internal to 
the IS6100 element at the right end of Inl04 coupled with 
right-hand primers in the adjacent chromosomaly id Y gene did 
not reveal a junction, suggesting that a large insertion may be 
present at this end in the serovar Emek strain.
Identification of resistance genes. When the resistance pro­
files were examined (Table 3), only four of the strains, SRC49 and 
SRC50 (both serovar Paratyphi B dT + isolates) and SRC10 
and SRC11 (both serovar Kiambu isolates), were resistant to 
all antibiotics in the standard SGIl-containing DT104 set (Ap, 
Cm and FI, Sm and Sp, Su, and Tc). Resistance to trim etho­
prim (Tp) was observed in seven strains and resistance to 
gentamicin (Gm) in one strain. The nine strains were also 
screened for the presence of each of the genes and open 
reading frames (ORFs) found in Inl04 (see Fig. IB) using 
pairs of primers internal to the genes (Table 1). The standard 
SGI1 resistance phenotype (ApCmFlSmSpSuTc) and resis­
tance gene complement, aadA2, blaPl, still, tetA(G), and floR, 
consistent with the presence of an integron identical to or 
closely related to Inl04, were only present in the two Paratyphi 
B dT+ strains (Table 3). Hence, most of the strains contained 
a variant of SGI1. Consistent with this conclusion, five strains 
lacked one or both of the cassette-associated resistance genes 
aadA2 (Sm and Sp) and blaPl (Ap) (Table 3). In the serovar
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TABLE 3. Properties of Salmonella spp. containing SGI1 or its variants
Strain Serovar
Antibiotic resistance profile" Resistance genes
Ap Fl/Cm Sm/Sp Su Tc Tp Gm Cp Na blaPl ftoR aadA2 sull tetG dfrAl dfrAlO
SRC 4 Derby R R R R R R - + + + + + -
SRC 5 Cerro R R R R R R R + + - + + + -
SRC 10 Kiambu R R R R R R + + + + + - +
SRC 11 Kiambu R R R R R R R R + + + + + - +
SRC 19 Emek R R R R R R - + - + + + -
SRC 38 Dusseldorf R R R R R R + + - + + + -
SRC 46 Infantis R R R - - + + - - +
SRC 49 Paratyphi B dT+ R R R R R + + + + + - -
SRC 50 Paratyphi B dT+ R R R R R + + + + + - -
DT104-2 Typhimurium R R R R R + + + + + - -
a Antibiotics: Ap, ampicillin (32 jxg/ml); Cm, chloramphenicol (10 fxg/ml); Gm, gentamicin (2.5 jxg/ml); Sm, streptomycin (25 fxg/ml); Sp, spectinomycin (50 pig/ml); 
Su, sulfamethoxazole (550 fug/ml); Tc, tetracycline (20 jxg/ml); Tp, trim ethoprim  (50 fxg/ml); Cp, ciprofloxacin (2 pig/ml); Na, nalidixic acid (50 pig/ml). Florfenicol (FI) 
resistance was tested by streaking isolates onto LB-agar containing 15 fxg/nil o f florfenicol.
Infantis strain, the floR  and tet(G) genes as well as orfl and 
orf2 (Fig. IB), which can be lost together if recombination 
between the duplicated 5 '-CS or 3'-CS regions occurs (3), were 
also missing, indicating loss of the central region.
Because seven of the nine strains were resistant to tr i­
methoprim, additional screens for two trimethoprim resistance 
genes that have been detected previously in SGI1 variants (3, 
10, 12) were also performed. These were for the dfrAl gene, 
which is found in a gene cassette (35), and the dfrAlO gene 
(27), which is found associated with CR1 (32). The two Ki­
ambu strains, which contain the five resistance genes of Inl04 
but were additionally resistant to trimethoprim, also included 
the dfrAlO gene (Table 3) and CR1. The serovar Infantis strain 
also included CR1 and the dfrAlO gene. Four strains included 
the cassette-associated dfrAl gene either alone or together 
with either the cassette-associated twtiT? or blaPl gene, suggest­
ing that one or both of the cassette arrays had been exchanged.
Variation in the gene cassettes. The regions containing gene 
cassettes were amplified using standard primers in the 5'-CS 
and 3'-CS of class 1 integrons (21) (Fig. IB). The DT104 
control strain as well as the serovar Kiambu and serovar Para­
typhi B strains yielded the 1.0- and 1.2-kb amplicons contain­
ing, respectively, the aadA2 and blaPl cassettes, as expected 
for Inl04 (SGI1). However, the serovar Derby strain, which 
does not include the blaPl gene, gave an indistinguishable 
pattern (Fig. 2, top panel), indicating that the cassette ampli- 
con sizes alone are insufficient to reliably indicate the presence 
of the original In l04 configuration (Fig. 1).
Digestion of the PCR fragments with the restriction enzymes 
R sal and Tsp5091 was therefore used to distinguish and more 
accurately identify the cassette arrays. For the serovar Kiambu 
and serovar Paratyphi strains, where both the aadA2 and blaPl 
cassette had been detected (Table 3), the restriction fragment 
patterns were identical to that of the M R DT104 (Inl04 type) 
control (Fig. 2, lower panel). However, the serovar Derby 
strain yielded a different pattern, confirming that it does not 
contain the blaPl cassette found in SGIl-continaing DT104. 
The three strains that apparently yielded a single 1.2-kb PCR 
product (Fig. 2, top panel) were differentiated into two types, 
one (serovars Cerro and Dusseldorf) with two different cas­
sette arrays and one (serovar Emek) with one array. The frag­
ments seen in digests from the Emek strain were also seen in
/
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FIG. 2. Characterization of the cassette arrays. PCR amplification 
products (top panel) of cassette regions (using primers LI and R l)  and 
Rsal-generated restriction endonuclease fragments from them (bot­
tom panel) were separated on agarose gels. Size markers are a 100-bp 
ladder.
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FIG. 3. Maps of Inl04 variants. Features are as in Fig. IB, and the vertical arrow indicates the right-hand boundary of SGI1. Regions associated 
with the additional dfrAlO genes are indicated above, with CR1 as a shaded box and the unique region including the dfrAlO gene as a hatched box. 
The strain or strains from which each map is derived, together with the SGI1 designation, are indicated on the left.
the serovars Cerro, Derby, and Dusseldorf digests, where they 
are combined with bands corresponding to either the aadA2 
amplicon (seen alone in serovar Infantis) or the blaPl ampli- 
con.
The Infantis strain yielded a single 1.0-kb product, consistent 
with the presence of only one attll site containing the aadA2 
cassette in this strain, and this was confirmed by sequencing. 
To identify the cassette array in the isolates which contained 
the dfrAl gene, the single 1.2-kb product from serovar Emek 
was sequenced. It contained the dfrAl cassette with the orfC 
cassette and is identical to a cassette array reported in Vibrio 
cholerae (46) (GenBank accession no. AF455254), Escherichia 
coli (AB161449), and Salmonella spp. (AB186122). The restric­
tion fragment analysis indicated that the same cassette array 
was also present in serovars Cerro, Derby, and Dusseldorf, and 
this was confirmed by PCR using a primer in each cassette. 
Hence, the Cerro and Dusseldorf strains include both the 
dfrA l-orfC and blaPl cassette arrays and serovar Derby in­
cludes dfrAl-oriC  with aadA2 (Fig. 3).
Location of the gene cassettes. As there is no a priori reason 
why the cassette arrays amplified could not have arisen from
integrons on resident plasmids rather than the integron in 
SGI1, further mapping was perform ed to confirm that the gene 
cassettes were part of the integron in SGI1 and to assign the 
cassettes to the left- or right-hand attll site. This was achieved 
by PCR using one primer within the cassette and one in a 
region unique to the surroundings of the left- or right-hand 
attll site (Fig. IB). These were within S026 in the SGI1 back­
bone or in the floR  gene for the left side and in the groEL 
region or orf5 for the right side (Table 1, Fig. IB). The assign­
ments are shown in Fig. 3. The serovar Emek strain was found 
to have the d frA l-orfC cassette combination only on the left- 
hand side. A  1.2-kb groEL-sull product was generated by am­
plification using the groEL-F and QS-2 primers (Table 1) and 
sequenced to determine the structure of the right-hand side. A 
deletion that removes both the gene cassette and 472 bp of 
adjacent sequences, including part of the attll site and all of 
qacEA.1, and is identical to a deletion found in TnffZO (23) 
(GenBank accession no. X53635) was present in this position.
Structure of the SGI1 integron variants. A complete map of 
each In l04 homologue (Fig. 3) was obtained by establishing 
PCR linkage between most adjacent gene pairs using the for-
V o l . 187, 2005 SGI1 IS W ID E L Y  D IS T R IB U T E D  IN  5. ENTERICA  4407
II ' .........  1 ----------------------- j CKl iz z z z z a --------------------------------
 ►  ►  ►  ►  ►  ►





FIG. 4. Mapping the CRl-dfrAlO  region. The primer combinations used to link genes in serovar Kiambu and serovar Infantis strains that 
possessed CR1 are shown. Primer sequences are listed in Table 1.
ward prim er of the first with the reverse primer of the second 
as well as longer linkages (Table 1). Linkage between orf2 
and tetA(G ) was established by Southern hybridization with 
tetA(G) and CR3 digoxigenin-labeled probes to Bsal-digested 
whole-cell DNA. As predicted from the DNA sequence of 
SGI1 (4), a 4.1-kb Bsal fragment hybridized with the tetA(G) 
and orf2 probes in all the SGIl-containing strains except se­
rovar Infantis. The presence of the CRA-dfrAlO region was 
confirmed, and its location was determined using PCR primers 
in the relevant cassettes with a primer in CR1 to link it to the 
right-hand or left-hand cassette array (Fig. 4). The integrons 
detected here include the original SGI1 (4) as well as the 
previously identified types designated SGI1-A, SGI1-D, and 
SGI1-F (3, 11, 12). In addition, two new types were found and 
designated SGI1-I (in serovar Derby) and SGI1-J (in serovar 
Emek) using the next available letters.
DISCUSSION
Since the discovery of genomic island SGI1 containing Inl04 
in S. enterica DT104 strains, SGI1 or SGI1 homologues with an 
integron related to Inl04 have been found in several serovars 
of S. enterica. The range now includes serovar Typhimurium 
phage types DT104, DT120, DT12, D T I, and U302 (4, 6) and 
serovars Agona (3, 4, 7, 10), Paratyphi B dT+ (24, 25, 44; this 
study), Albany (12), Meleagridis (14), and Newport (13) as 
well as serovars Emek, Cerro, Derby, Dusseldorf, Infantis, and 
Kiambu identified in this study. This wide distribution provides 
a strong indication that the SGI1 genomic island is a significant 
determinant of multiple drug resistance in Salmonella and is 
clearly able to move from strain to strain.
One way in which this horizontal gene transfer could occur 
is by Int-m ediated excision of SGI as a circular molecule, which 
is then packaged into a bacteriophage and transduced into 
another strain, and such transduction has been demonstrated 
(41). However, for each serovar, horizontal transfer need not 
necessarily have occurred on many occasions. The selective 
advantage conferred by the resistance genes in the many en­
vironments where antibiotics are used heavily, such as in the 
intensive rearing of food-producing animals, means that a sin­
gle cell that had acquired SGI1 could be amplified (clonal ex­
pansion) and come to represent a significant fraction of the 
population of that serovar. The larger number of bacteria aris­
ing from such amplification would in turn increase the likeli­
hood of spread of the new strain to new locations, and this is
clearly what has occurred in the case of SGIl-containing 
D T I04 (36).
SGI1-A has been shown be prevalent in poultry in Belgium 
(11), but whether any of the remaining serovars described here 
or by others are prevalent, particularly in food-producing an­
imal populations, in the countries (including Australia) from 
which the isolates studied here originated remains to be estab­
lished. The pairs of the same serovar isolates (Paratyphi B dT+ 
and Kiambu) identified here, though not known to be linked 
epidemiologically, could nonetheless be members of a single 
clonal line. In support of this, Xbal-digested chromosomal 
DNA from the Paratyphi B dT+ strains gave identical pulsed- 
field gel electrophoresis profiles (R. S. Levings and S. P. Djord- 
jevic, unpublished observations). In addition, the properties of 
the multidrug resistance region in an S. enterica serovar Emek 
isolated in the United Kingdom (34) are consistent with its 
being within an SGI1 variant that is the same as SGI1-J in the 
serovar Emek strain studied here. Moreover, it appears that 
the absence of SGIl-containing DT104 in Australia does not 
reflect an absence of SGIl-containing strains belonging to 
other serovars.
Variation in the resistance gene content of the SGI1 inte­
gron observed here is likely to have arisen mostly by homolo­
gous recombination between identical segments, one within 
the integron in the SGI1 island and the second in a coresident 
plasmid or a smaller nonreplicating circular molecule. The lat­
ter can arise from a plasmid via homologous recombination as 
demonstrated for the CK-dfrAlO-sull circle (32). Gene ex­
change by homologous recombination is likely to represent an 
important route for the exchange of gene cassettes in class 1 
integrons because they are flanked by two regions, the 5'-CS 
and the 3'-CS, that are present in most class 1 integrons (16, 
17, 32). This mechanism has been demonstrated experimen­
tally (30, 31) and is likely to be responsible for the substitution 
of the dfrAl-oriC  cassette array for either the aadA2 or the 
blaPl cassette in the isolates studied here and previously.
The deletion removing part of the attll site found in one 
strain studied here (SGI1-J) could also have been acquired by 
this route from Tn610 (23) and, as Tn610 was originally found 
in Mycobacterium fortuitum, this suggests that this transposon 
has a very broad distribution. Previous claims of movement of 
gene cassettes from Inl04 into plasmids containing a class 1 
integron via site-specific recombination (40) are unlikely to be 
correct. Cassette exchange most probably occurred by homol­
ogous recombination, granted that the SGIl-containing DT104
4408 L EV IN G S E T  AL. J. B a c t e r i o l .
strains used are wild type and hence recombination proficient 
Small nonreplicating circular molecules that have arisen by 
homologous recombination from a class 1 integron that has 
direct duplication of either the 5'-CS or 3'-CS, such as those 
found in In i04 and those in CRl(orf513)-containing integrons 
(32, 42), are also likely to be im portant These circles, once 
formed, can recombine into new locations, e.g., plasmids that 
contain a copy of any sequence included within them. The 
dfrAlO gene has been shown experimentally to move in this 
way (32) and is likely to have entered the In 104 variants that 
contain it via this route. This route is also one that could lead 
to the movement of the floR-tet(G) region onto a plasmid that 
contains an integron and thence out into the broader popula­
tion of Enterobactenaceae. Indeed, such a plasmid may repre­
sent the original source of these genes in Inl04.
A particularly surprising finding of this study was that SGI1 
or an SGI 1 variant was found in 8 of the 39 strains included in 
the study that were isolated from humans with severe Salmo­
nella infections. Recently, a single case of a human infection with 
SGI1-containing serovar Agona (11) and sporadic cases of sero­
var Paratyphi B dT+ infections in humans in Canada and the 
United Kingdom (25, 44) have also been reported. The United 
Kingdom Paratyphi B strains are associated with owners of 
tropical fish tanks, as are the Australian isolates reported here. 
As these serotypes are historically viewed as having low infec- 
tivity for humans, it was suggested that the presence of SGI1 
may increase the likelihood of human infection (25). Our find­
ings also support the contention that the presence of SGI1 in­
troduces a determinant that may predispose to human infection. 
However, the possibility that these human infections simply re­
flect a widespread distribution of SGI1-containing Salmonella 
serovars in animal populations in the Southeast Asia-Australia 
region and in poultry in Belgium is still to be eliminated.
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